After Cutting 150 Ranbaxy Laboratories Execs, Sun Pharma Takes the Ax to Some R&D Workers

MUMBAI: Sun PharmaceuticalBSE -1.89 % Industries is cutting staff again as it digests the $3.2-billion acquisition of Ranbaxy LaboratoriesBSE 5.63 %. Facing the axe this time are research and development staff, a move that comes a month after about 150 senior executives were asked to leave.

Close to 15 employees from the R&D department are to exit as Sun integrates a combined staff base that's 30,000 strong.

lHelp employers find you! Check out all the jobs and post your resume.

Back to news